DISPERZISTA
Live / Registered — Registered — international registration renewed (as of 23 Nov 2024)
What this means for you
Registered since 11 Oct 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79185805
- Registration number
- 5056967
- Mark type
- Stylized text
- Filed
- 18 Nov 2015
- Published for opposition
- 26 Jul 2016
- Registered
- 11 Oct 2016
- Attorney of record
- Mainak H. Mehta
Goods and services
- Class 001 — Chemicals: Specialized excipient mixture without the pharmaceutical ingredient, used in the manufacture of rapidly disintegrating pharmaceutical tablets; chemical additives for use in the manufacture of food; chemical food additives for use in the manufacture of supplements; chemical food additives for use in the manufacture of nutritional supplements; chemicals, namely, disintegrating modifiers for use in the field of coating materials; excipients for use in the manufacture of pharmaceutical preparations and supplements; chemical agents for manufacturing supplements; chemicals used in industry and science; chemical preparations for use in the manufacture of pharmaceuticals, namely, raw materials and auxiliaries for the direct compression manufacturing of rapidly disintegrating tablets
- Class 005 — Pharmaceuticals: Delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of nutritional supplements; dietary and nutritional supplements; dietary food supplements; dietary and nutritional supplements containing cellulose; cellulose ethers for pharmaceutical purposes; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of pharmaceutical preparations; health food supplements; medicinal preparations for the mouth to be applied in the form of films, capsules, tablets and compressed tablets; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the rapidly disintegrating of a wide variety of therapeutic agents
Owner
- Daicel Corporation, Osaka-shi Osaka, JP
- Daicel Corporation, JP
- Daicel Corporation, JP
Prosecution history
- 11 Oct 2025 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 23 Nov 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 23 Nov 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 23 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 11 Jul 2023 — POST REGISTRATION ACTION MAILED - SEC. 71 & 15
- 24 Mar 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Jan 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 26 Sept 2022 — TEAS SECTION 71 & 15 RECEIVED
- 11 Oct 2021 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 14 Dec 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Dec 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Mar 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 16 Feb 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 16 Feb 2017 — FINAL DISPOSITION PROCESSED
- 11 Jan 2017 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB